E. A. Savchenko

E. A. Savchenko

Auto-generated profile, based on publicly available information

E. A. Savchenko

Burdenko Neurosurgical Center

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
ETE.E. Tyagunova
E.E. Tyagunova
SDSergey Drozd
Sergey Drozd
OKO.V. Kalennik
O.V. Kalennik
NSN.S. Samoylenkova
N.S. Samoylenkova
ESE.A. Savchenko
E.A. Savchenko
GPGalina Pavlova
Galina Pavlova
Культуры глиом имеют широкий спектр применения: в фундаментальных исследованиях опухолевых процессов, персонализированной медицине для подбора схем лечения, учитывающих индивидуальные особенности пациента, а также в фармакологии для оценки эффективности действия лекарственных средств на опухоль. При этом часто отмечается подавление роста культуры глиомы в целом без снижения степени злокачественности. При отмене препаратов может происходить вытеснение пула предшествующих клеток более злокачественными клонами, поэтому важное значение имеет определение степени злокачественности клеток в культуре. В дальнейшем изучение степени злокачественности клеток культуры глиомы, полученной от пациента во время операции, может быть использовано для подбора персонализированной терапии, наилучшим образом подходящей данному пациенту. ЦЕЛЬ ИССЛЕДОВАНИЯ Изучение связи между экспрессией маркерных генов TUBB3, CD133, CDK4, CDK6, CIRBP, DR4, DR5, EGFR, FGFR, FSHR, GDNF, GFAP, L1CAM, LEF1, MAP2, MDM2, MELK, NANOG, NOTCH2, OCT4, OLIG2, PDGFRA, PDGFA, PDGFB и SOX2 и степенью злокачественности клеток в культурах глиом и создание прогностической модели в виде уравнения на основе регрессионного анализа. МАТЕРИАЛ И МЕТОДЫ С помощью количественной полимеразной цепной реакции в реальном времени была проанализирована экспрессия 25 маркерных генов в 22 образцах культур глиом человека, полученных от пациентов, проходивших лечение в ФГАУ «Национальный медицинский исследовательский центр нейрохирургии им. акад. Н.Н. Бурденко» Минздрава России. При статистической обработке полученных данных, проведенной с помощью программного обеспечения IBM SPSS Statistics 26.0 (StatSoft Inc., США), для оценки нормальности распределения анализировали критерии Колмогорова—Смирнова и Шапиро—Уилка, при сравнительной статистике использовали непараметрические критерии Джонкхиера—Терпстры и Спирмена. РЕЗУЛЬТАТЫ Была получена прогностическая модель для определения степени злокачественности клеток в культурах глиом III и IV Grade с помощью оценки экспрессии маркерных генов MDM2, MELK, SOX2, CDK4, DR5 и OCT4 с прогностической точностью 83% (информационный критерий Акаике равен —55,125).

30 December 2025 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
YSYahya Ali Sliman
Yahya Ali Sliman
SPSvetlana Pavlova
Svetlana Pavlova
ESE.A. Savchenko
E.A. Savchenko
NSN.S. Samoilenkova
N.S. Samoilenkova
AOA.V. Ovechkina
A.V. Ovechkina
GPGalina Pavlova
Galina Pavlova
Aptamers can increase human glioblastoma cell death rate after exposure to radiotherapy. Cell cultures derived from human glioblastomas allow for selection of effective combined therapy. Objective. To analyze viability of human glioblastoma cell cultures exposed to EGFR-specific aptamers U31, GR20, and GR200 compared to combination of these aptamers and radiotherapy (20 Gy). Methodology. G22 and Sus\fP2 cell cultures were harvested from tumor tissue. They were exposed to aptamers (10 μM, 72 hours) and irradiated once with 20 Gy. We analyzed viability using flow cytometry. Results. In G22 cell culture, aptamer U31 reduces apoptosis by 45.8%, but increases necrosis by 67.5%, while GR20 and GR200 increase two types of death (apoptosis and necrosis). In Sus\fP2 culture, all three aptamers significantly increased apoptosis while proportion of necrosis decreased. The most significant decrease in the number of necrotic cells was observed for aptamer U31 (by 77.7%). Radiotherapy combined with aptamers was followed by the following effects for G22 cell culture: U31 and GR200 enhance apoptosis (by 59.4%) and necrosis (by 57.7%), aptamer GR20 increases necrosis by 28.3%. In Sus\fP2 culture, U31 aptamer enhances apoptosis by 132.9% and necrosis by 52.9%, GR20 — 125.4% and 17.7%, GR200 — 27.4% and 30.6%, respectively. Conclusion. Aptamers have different effects on glioblastoma cell cultures. For Sus\fP2, a combination of radiotherapy with GR20 aptamer is optimal. Either a single application of U31 aptamer or combination of radiotherapy and GR200 aptamer is optimal for G22 cell culture. This result demonstrates the importance of combined therapy and preliminary studies in cell cultures for individualized approach to each CNS tumor.

15 January 2019 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
VSV. E. Shevchenko
V. E. Shevchenko
IBIgor Bryukhovetskiy
Igor Bryukhovetskiy
ESE. A. Savchenko
E. A. Savchenko
NAN. E. Arnotskaya
N. E. Arnotskaya
Изучение взаимодействия белков внеклеточного матрикса с рецепторами CD133+ стволовых клеток и CD133– дифференцированных клеток глиомы

3 April 2026 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
VIValeria Ivko
Valeria Ivko
VMV.E. Makeeva
V.E. Makeeva
OAOlga Antipova
Olga Antipova
ESE.A. Savchenko
E.A. Savchenko
IPIgor Pronin
Igor Pronin
Alexey KopylovAlexey Kopylov
Alexey Kopylov
Glioblastoma or grade IV glioma is characterized by extremely poor prognosis. Resistance to radio- / chemotherapy and recurrences are associated with tumor stem cells. Transmembrane protein CD133 is considered a potential marker of tumor stem cells. To overcome the limitations of detecting cellular CD133 by antibodies, potential of aptamers (nucleic acid-based molecular recognition elements) is being explored. To obtain reproducible results, it is necessary to study the interaction of fluorescent aptamers to CD133 with standard cell lines and cell cultures derived from patient tumors using various methods. Objective. To detect the CD133 marker in continuous cell cultures of patient-derived GB cells using fluorescent DNA aptamers by flow cytometry. Material and methods. Fluorescein (FAM)-labeled DNA aptamers of the Cs and Ap series were used to detect the CD133 marker. Three continuous cell cultures from the Burdenko Neurosurgical Center Biobank were tested using flow cytometry. Burdenko: BU881 (107), G01, and Sus (harvested from postoperative GB tissues). Results. CD133 DNA aptamers at a concentration of 1 μM yield positive signals for GB cell cultures. Their magnitude correlates with CD133 gene transcription. Fluorescence signal shift (∆MFI) for FAM DNA aptamers of the Cs and Ap series is greater for BU881 cells (1942 and 5449 c.u., respectively) than for G01 cells (1469 and 1817 c.u., respectively). This is consistent with CD133 gene transcription. There is no fluorescence signal shift for Sus cells with minimal CD133 gene transcription. Conclusion. Fluorescein-labeled DNA aptamers of the Cs and Ap series at a concentration of 1 μM enable detection of the CD133 marker in continuous cell cultures of GB through flow cytometry.

30 December 2025 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
SDSergey Drozd
Sergey Drozd
OKO.V. Kalennik
O.V. Kalennik
DLD.S. Lukash
D.S. Lukash
YSYahya Ali Sliman
Yahya Ali Sliman
NSN.S. Samoilenkova
N.S. Samoilenkova
GPGalina Pavlova
Galina Pavlova
Differentiation of high-grade gliomas (WHO grades III and IV) is still a pressing issue despite advances of molecular biology in tumor stratification. Even with a comprehensive approach to differential diagnosis, uncertainty sometimes arises in classifying a glioma into a particular grade. This can complicate prognosis and selection of appropriate treatment. Objective. To develop an effective method for differentiating high-grade gliomas based on marker gene expression analysis. Material and methods. We analyzed expression of 31 marker genes in high-grade glioma samples (Grade III and IV) diagnosed with isocitrate dehydrogenase (IDH)-mutated oligodendroglioma, IDH-mutated astrocytoma and IDH-wildtype glioblastoma. Real-time polymerase chain reaction was used. Spearman rank correlation method was applied to select genes whose expression was most closely related to glioma grade. Gene expression and their ratios were compared in groups of Grade III and IV malignant gliomas using the Mann-Whitney test. Results. Expression ratios of three genes (CD44, CIRBP, and SOX2) were selected to assess malignancy grade. Expression ratios for these genes distinguishes IDH wild-type glioblastomas from IDH-mutated astrocytomas and oligodendrogliomas. They also have a stronger correlation with glioma grade than expression of each individual marker gene. Conclusion. Original method based on marker gene expression ratios does not replace standard diagnostic protocols, but may be an additional tool for optimized diagnostic process. This approach will be valuable to minimize errors and personalize therapeutic strategies. The last one is critical for prognosis.